Aktuellt
SENASTE
Redeye gives its initial comments on the Q2 2024 report from Precise Biometrics. Sales was SEK20.6m, landing c11% below our estimates. However, the gross margin remains strong, and we are encouraged to see a sequential uptick in the ARR, which we consider one of the most important aspects of the investment case. We expect to make only minor estimate changes following the report.
LÄS MER
